Page last updated: 2024-10-25

diazepam and Malignant Carcinoid Syndrome

diazepam has been researched along with Malignant Carcinoid Syndrome in 1 studies

Diazepam: A benzodiazepine with anticonvulsant, anxiolytic, sedative, muscle relaxant, and amnesic properties and a long duration of action. Its actions are mediated by enhancement of GAMMA-AMINOBUTYRIC ACID activity.
diazepam : A 1,4-benzodiazepinone that is 1,3-dihydro-2H-1,4-benzodiazepin-2-one substituted by a chloro group at position 7, a methyl group at position 1 and a phenyl group at position 5.

Malignant Carcinoid Syndrome: A symptom complex associated with CARCINOID TUMOR and characterized by attacks of severe flushing of the skin, diarrheal watery stools, bronchoconstriction, sudden drops in blood pressure, edema, and ascites. The carcinoid tumors are usually located in the gastrointestinal tract and metastasize to the liver. Symptoms are caused by tumor secretion of serotonin, prostaglandins, and other biologically active substances. Cardiac manifestations constitute CARCINOID HEART DISEASE. (Dorland, 27th ed; Stedman, 25th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Eisenkraft, JB1
Dimich, I1
Miller, R1

Other Studies

1 other study available for diazepam and Malignant Carcinoid Syndrome

ArticleYear
Ketamine-diazepam anaesthesia in a patient with carcinoid syndrome.
    Anaesthesia, 1981, Volume: 36, Issue:9

    Topics: Aged; Anesthesia, Intravenous; Diazepam; Humans; Ketamine; Male; Malignant Carcinoid Syndrome

1981